Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Afamin is a member of the hepatokine that are strongly associated with various metabolic diseases. The relationship between afamin and nonalcoholic fatty liver disease (NAFLD) remains unclear. This study aimed to explore the correlation between serum afamin levels and NAFLD. We analyzed 88 NAFLD pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Shenghui Chen, Zhening Liu, Li Cen, Jinghua Wang, Juanwen Zhang, Xiaofeng Zhang, Chengfu Xu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Canadian Journal of Gastroenterology and Hepatology
Online Access:http://dx.doi.org/10.1155/2022/7175108
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849695454101504000
author Shenghui Chen
Zhening Liu
Li Cen
Jinghua Wang
Juanwen Zhang
Xiaofeng Zhang
Chengfu Xu
author_facet Shenghui Chen
Zhening Liu
Li Cen
Jinghua Wang
Juanwen Zhang
Xiaofeng Zhang
Chengfu Xu
author_sort Shenghui Chen
collection DOAJ
description Afamin is a member of the hepatokine that are strongly associated with various metabolic diseases. The relationship between afamin and nonalcoholic fatty liver disease (NAFLD) remains unclear. This study aimed to explore the correlation between serum afamin levels and NAFLD. We analyzed 88 NAFLD patients and 88 age- and sex-matched healthy controls who took their health examinations at the First Affiliated Hospital, Zhejiang University School of Medicine. The association was further confirmed in 22 biopsy-confirmed NAFLD patients and 36 healthy controls. Serum afamin levels were evaluated using an enzyme-linked immunosorbent assay (ELISA). NAFLD patients had significantly higher serum afamin levels than the healthy controls (14.79 ± 5.04 mg/L versus 10.83 ± 3.24 mg/L; P<0.001). Serum afamin levels were positively correlated with metabolic parameters including the body mass index, waist circumference, systolic blood pressure, liver enzymes, and lipid profiles. A multiple regression analysis showed that serum afamin levels were independently related to the risk of NAFLD (OR: 1.289, 95% CI, 1.141–1.456; P<0.001). The receiver operating characteristic (ROC) analysis showed that the area under curve (AUC) of serum afamin plus the BMI for detecting NAFLD was 0.878. In participants with liver biopsies, the serum afamin plus the BMI detected NAFLD with an AUC of 0.758. In conclusion, serum afamin levels were positively associated with prevalence and risk of NAFLD, and serum afamin plus the BMI had a high diagnostic performance for NAFLD. This study provides epidemiological evidence of afamin in NAFLD.
format Article
id doaj-art-d08d4b80b02c4d8d8f9f137e2e4ccf19
institution DOAJ
issn 2291-2797
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology and Hepatology
spelling doaj-art-d08d4b80b02c4d8d8f9f137e2e4ccf192025-08-20T03:19:46ZengWileyCanadian Journal of Gastroenterology and Hepatology2291-27972022-01-01202210.1155/2022/7175108Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver DiseaseShenghui Chen0Zhening Liu1Li Cen2Jinghua Wang3Juanwen Zhang4Xiaofeng Zhang5Chengfu Xu6GastroenterologyGastroenterologyGastroenterologyGastroenterologyDepartment of Laboratory MedicineGastroenterologyGastroenterologyAfamin is a member of the hepatokine that are strongly associated with various metabolic diseases. The relationship between afamin and nonalcoholic fatty liver disease (NAFLD) remains unclear. This study aimed to explore the correlation between serum afamin levels and NAFLD. We analyzed 88 NAFLD patients and 88 age- and sex-matched healthy controls who took their health examinations at the First Affiliated Hospital, Zhejiang University School of Medicine. The association was further confirmed in 22 biopsy-confirmed NAFLD patients and 36 healthy controls. Serum afamin levels were evaluated using an enzyme-linked immunosorbent assay (ELISA). NAFLD patients had significantly higher serum afamin levels than the healthy controls (14.79 ± 5.04 mg/L versus 10.83 ± 3.24 mg/L; P<0.001). Serum afamin levels were positively correlated with metabolic parameters including the body mass index, waist circumference, systolic blood pressure, liver enzymes, and lipid profiles. A multiple regression analysis showed that serum afamin levels were independently related to the risk of NAFLD (OR: 1.289, 95% CI, 1.141–1.456; P<0.001). The receiver operating characteristic (ROC) analysis showed that the area under curve (AUC) of serum afamin plus the BMI for detecting NAFLD was 0.878. In participants with liver biopsies, the serum afamin plus the BMI detected NAFLD with an AUC of 0.758. In conclusion, serum afamin levels were positively associated with prevalence and risk of NAFLD, and serum afamin plus the BMI had a high diagnostic performance for NAFLD. This study provides epidemiological evidence of afamin in NAFLD.http://dx.doi.org/10.1155/2022/7175108
spellingShingle Shenghui Chen
Zhening Liu
Li Cen
Jinghua Wang
Juanwen Zhang
Xiaofeng Zhang
Chengfu Xu
Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
Canadian Journal of Gastroenterology and Hepatology
title Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
title_full Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
title_fullStr Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
title_full_unstemmed Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
title_short Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease
title_sort association between serum afamin levels with nonalcoholic associated fatty liver disease
url http://dx.doi.org/10.1155/2022/7175108
work_keys_str_mv AT shenghuichen associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT zheningliu associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT licen associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT jinghuawang associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT juanwenzhang associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT xiaofengzhang associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease
AT chengfuxu associationbetweenserumafaminlevelswithnonalcoholicassociatedfattyliverdisease